
David Fidei
Examiner (ID: 6483)
| Most Active Art Unit | 3728 |
| Art Unit(s) | 1775, 2404, 3788, 3208, 3728, 2401, 2899 |
| Total Applications | 3497 |
| Issued Applications | 2707 |
| Pending Applications | 110 |
| Abandoned Applications | 680 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19884353
[patent_doc_number] => 12270047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Engineered multi-component system for identification and characterisation of T-cell receptors and T-cell antigens
[patent_app_type] => utility
[patent_app_number] => 16/863119
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 49
[patent_no_of_words] => 41208
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863119
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863119 | Engineered multi-component system for identification and characterisation of T-cell receptors and T-cell antigens | Apr 29, 2020 | Issued |
Array
(
[id] => 16376623
[patent_doc_number] => 20200325465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => ENHANCING MICROBIAL METABOLISM OF C5 ORGANIC CARBON
[patent_app_type] => utility
[patent_app_number] => 16/864098
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864098
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864098 | ENHANCING MICROBIAL METABOLISM OF C5 ORGANIC CARBON | Apr 29, 2020 | Abandoned |
Array
(
[id] => 17688097
[patent_doc_number] => 20220195389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => METHODS OF IMPROVING THE LONGEVITY OF IMMUNE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/604714
[patent_app_country] => US
[patent_app_date] => 2020-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10245
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17604714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/604714 | METHODS OF IMPROVING THE LONGEVITY OF IMMUNE CELLS | Apr 16, 2020 | Pending |
Array
(
[id] => 16557046
[patent_doc_number] => 20210002194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => PROCESS OF SEPARATING COMPONENTS OF A FERMENTATION BROTH
[patent_app_type] => utility
[patent_app_number] => 16/848430
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21539
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848430 | PROCESS OF SEPARATING COMPONENTS OF A FERMENTATION BROTH | Apr 13, 2020 | Abandoned |
Array
(
[id] => 16770885
[patent_doc_number] => 10981974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Cell culture media containing combinations of proteins
[patent_app_type] => utility
[patent_app_number] => 16/847337
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 26
[patent_no_of_words] => 48357
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847337
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847337 | Cell culture media containing combinations of proteins | Apr 12, 2020 | Issued |
Array
(
[id] => 16283976
[patent_doc_number] => 20200277578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => HETERO-TRANSGLYCOSYLASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/844489
[patent_app_country] => US
[patent_app_date] => 2020-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20409
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16844489
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/844489 | HETERO-TRANSGLYCOSYLASE AND USES THEREOF | Apr 8, 2020 | Abandoned |
Array
(
[id] => 17702727
[patent_doc_number] => 20220202733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PROTEIN NANO- OR MICROPARTICLES AS ARTIFICIAL INCLUSION BODIES
[patent_app_type] => utility
[patent_app_number] => 17/602402
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602402
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602402 | PROTEIN NANO- OR MICROPARTICLES AS ARTIFICIAL INCLUSION BODIES | Apr 7, 2020 | Pending |
Array
(
[id] => 16361388
[patent_doc_number] => 20200318139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => GENOME ENGINEERING WITH TYPE I CRISPR SYSTEMS IN EUKARYOTIC CELLS
[patent_app_type] => utility
[patent_app_number] => 16/837395
[patent_app_country] => US
[patent_app_date] => 2020-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16837395
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/837395 | Genome engineering with type I CRISPR systems in eukaryotic cells | Mar 31, 2020 | Issued |
Array
(
[id] => 19373931
[patent_doc_number] => 12065480
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Crosslinked human or animal tissue products and their methods of manufacture and use
[patent_app_type] => utility
[patent_app_number] => 16/834824
[patent_app_country] => US
[patent_app_date] => 2020-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 12341
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16834824
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/834824 | Crosslinked human or animal tissue products and their methods of manufacture and use | Mar 29, 2020 | Issued |
Array
(
[id] => 17625781
[patent_doc_number] => 20220160796
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING OBESITY OR FATTY LIVER DISEASE, COMPRISING WEISSELLA HELLENICA WIKIM0103
[patent_app_type] => utility
[patent_app_number] => 17/433433
[patent_app_country] => US
[patent_app_date] => 2020-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17433433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/433433 | COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING OBESITY OR FATTY LIVER DISEASE, COMPRISING WEISSELLA HELLENICA WIKIM0103 | Feb 26, 2020 | Abandoned |
Array
(
[id] => 16073079
[patent_doc_number] => 20200190526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => PICHIA PASTORIS STRAINS FOR PRODUCING PREDOMINANTLY HOMOGENEOUS GLYCAN STRUCTURE
[patent_app_type] => utility
[patent_app_number] => 16/801466
[patent_app_country] => US
[patent_app_date] => 2020-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12619
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16801466
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/801466 | None | Feb 25, 2020 | Issued |
Array
(
[id] => 16312224
[patent_doc_number] => 20200290962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => Process for Making Beta 3 Agonists and Intermediates
[patent_app_type] => utility
[patent_app_number] => 16/795745
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795745
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795745 | Process for making beta 3 agonists and intermediates | Feb 19, 2020 | Issued |
Array
(
[id] => 16013491
[patent_doc_number] => 20200181588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => 2-O-Sulfation Enzyme Mutant and 3-O-Sulfation Enzyme Mutant, and Method for Using Same
[patent_app_type] => utility
[patent_app_number] => 16/795991
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 208
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795991
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795991 | 2-O-sulfation enzyme mutant and 3-O-sulfation enzyme mutant, and method for using same | Feb 19, 2020 | Issued |
Array
(
[id] => 18854131
[patent_doc_number] => 11851694
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-12-26
[patent_title] => High fidelity in vitro transcription
[patent_app_type] => utility
[patent_app_number] => 16/794318
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 26496
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16794318
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/794318 | High fidelity in vitro transcription | Feb 18, 2020 | Issued |
Array
(
[id] => 16009227
[patent_doc_number] => 20200179456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => CELL PREPARATIONS FOR EXTEMPORANEOUS USE, USEFUL FOR HEALING AND REJUVENATION IN VIVO
[patent_app_type] => utility
[patent_app_number] => 16/793296
[patent_app_country] => US
[patent_app_date] => 2020-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16793296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/793296 | Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo | Feb 17, 2020 | Issued |
Array
(
[id] => 16013627
[patent_doc_number] => 20200181656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => Industrial Fatty Acid Engineering General System for Modifying Fatty Acids
[patent_app_type] => utility
[patent_app_number] => 16/794156
[patent_app_country] => US
[patent_app_date] => 2020-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16794156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/794156 | Industrial Fatty Acid Engineering General System for Modifying Fatty Acids | Feb 17, 2020 | Abandoned |
Array
(
[id] => 17520767
[patent_doc_number] => 20220106616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => PRODUCTION OF CANNABINOIDS IN FILAMENTOUS FUNGI
[patent_app_type] => utility
[patent_app_number] => 17/429461
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429461 | PRODUCTION OF CANNABINOIDS IN FILAMENTOUS FUNGI | Feb 9, 2020 | Abandoned |
Array
(
[id] => 16925518
[patent_doc_number] => 11046982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Variant LovD polypeptides and their uses
[patent_app_type] => utility
[patent_app_number] => 16/784011
[patent_app_country] => US
[patent_app_date] => 2020-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17283
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784011
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784011 | Variant LovD polypeptides and their uses | Feb 5, 2020 | Issued |
Array
(
[id] => 19076689
[patent_doc_number] => 11946040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-02
[patent_title] => Adenine DNA base editor variants with reduced off-target RNA editing
[patent_app_type] => utility
[patent_app_number] => 16/781979
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 26
[patent_no_of_words] => 18069
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16781979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/781979 | Adenine DNA base editor variants with reduced off-target RNA editing | Feb 3, 2020 | Issued |
Array
(
[id] => 16312603
[patent_doc_number] => 20200291341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => PSEUDO SAMPLE CREATION METHOD AND APPARATUS, AND NUMERICAL MODEL CREATION SYSTEM AND METHOD
[patent_app_type] => utility
[patent_app_number] => 16/774048
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774048
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/774048 | PSEUDO SAMPLE CREATION METHOD AND APPARATUS, AND NUMERICAL MODEL CREATION SYSTEM AND METHOD | Jan 27, 2020 | Abandoned |